Psychedelic Stocks,Shroom News Revival Therapeutics Inks Deal With LTS Lohmann to Develop Oral Psilocybin Thin Film Strip By Dennis Mutua May 18, 2021 Life Sciences company focusing on research and development of treatments for medical needs and rare disorders Revival Therapeutics Ltd. (CSE: RVV) announced have signed an agreement deal with LTS Lohmann Therapie-Systeme AG to joi...
Psychedelic Stocks,Shroom News BetterLife Pharma Closes a Non-Brokered Private Placement By Dennis Mutua May 17, 2021 Life Sciences company specializing on developing second generation psychedelics compounds for treatment of mental disorders BetterLife Pharma Inc. (CSE: BETR) (OTCQB: BETRF) announced having closed a non-brokered private placement...
Shroom News Silo Pharma Submits Study of Using Psilocybin to Treat Parkinson’s Disease to be Reviewed by Ethics Board By Dennis Mutua May 14, 2021 Developmental stage biopharmaceutical company specializing on integrating traditional therapeutics with psychedelics to treat various mental conditions Silo Pharma Inc. (OTCMKTS: SILO) announced having submitted a study in which p...
Featured,Shroom News,Spotlight Stock PsyBio files For Provisional U.S Patent for Production of Psilocybin By Dennis Mutua May 13, 2021 Biotechnology company specializing in developing next generation biosynthetic psychoactive compounds to teat mental illnesses PsyBio Therapeutics Corp. (CVE: PSYB) (OTCPINK: PSYBF) announced having filed for provisional patent wit...
Psychedelic Stocks,Shroom News Numinus Wellness and Optimi Health Submit Psilocybin Extracts For Pre-Clinical Trial Application By Dennis Mutua May 12, 2021 Mental Health and wellness company Numinus Wellness Inc. (CVE: NUMI) and producer of finest strains of functional mushrooms from Cultivation to Consumer (CTC) Optimi Health Corp. (CSE: OPTI) (OTC: OPTHF) announced having submitted...
Psychedelic Stocks,Shroom News Tryp Inks Agreement With Clinlogix for Clinical Trial Support By Dennis Mutua May 11, 2021 Pharmaceutical company specializing in identifying and developing clinical-stage compounds for orphan diseases and other diseases with high unmet medical needs Tryp Therapeutics (CSE: TRYP) (OTCQB: TRYPF) announced having inked a ...
Psychedelic Stocks,Shroom News Jamaica’s Agriculture Minister Visits Psilocybin Company Wake Network By Dennis Mutua May 10, 2021 The Minister of Agriculture and Fisheries in Jamaica Hon. Floyd Green paid a visit to the cultivation facility of Wake Jamaica Limited, a subsidiary of leading psilocybin and medicinal mushroom production and developer of genomics...
Psychedelic Stocks,Shroom News Gilgamesh Concludes $27 Million Series A Financing Round By Dennis Mutua May 07, 2021 Preclinical biotechnology company focused on psychedelics therapies on mental illnesses Gilgamesh Pharmaceuticals announced having closed a $27 million Series A financing round. This latest financing round by the company was concl...
